Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5928_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
13 Мб
Скачать
☆
168 7 Histamine and antihistamines
https://t.me/med1917
Fig. 7.39: Alternative theory for the binding of cimetidine to the agonist site.
Fig. 7.40: Nitropyrrole derivative of cimetidine.
Fig. 7.41: An isocytosine ring incorporated into a moiety present in cimetidine.
7.8.4 Desolvation
The guanidino and thiourea groups are polar and hydrophilic. This implies that they are probably solvated (i.e., surrounded by a “water layer”). Before the hydrogen bond is established, the water layer has to be removed. The more solvated the group is, the more difficult the interaction with the receptor becomes. If desolvation is a factor influencing biological activity, a reduction of the polar group s olvati on should in­crease activity. One way to achieve this would be to increase the hydrophobic charac­ter of the terminus group of the molecule.
7.8 Cimetidine development 169
https://t.me/med1917
A study was carried out on a set of cimetidine analogs containing different flat aminal systems [Z, an aminal or aminoacetal is a functional group that has two amino groups attached to the same carbon atom: –C(NR
)(NR2)–; R may be hydrogen or an
2
alkyl group] in order to investigate whether there was any relationship between the antagonistic activity and the hydrophobic character of the aminal groups (Fig. 7.42).
Fig. 7.42: Analogs of cimetidine with flat aminal systems (Z).
This study showed that antagonistic activity was proportional to the hydrophobicity of the Z aminal unit and supported the theory of desolvation [eq. (7.1) and Fig. 7.43]:
log ð1=CÞ = 2.0 log π + 7.4(7:1)
An important finding is that the 2-nitroethene-1,1-diamine group behaves as an outlier (Fig. 7.43). The reasoning for this will be considered next.
Fig. 7.43: The antagonist activity is proportional to the hydrophobicity (log π) of the Z-aminal moiety.
170 7 Histamine and antihistamines
https://t.me/med1917
7.8.5 Development of the 2-nitroethene-1,1-diamine group
It was decided to see what would happen if the polar imine nitrogen of cimetidine was replaced b y a nonpolar carbon atom. This was expected to give rise to the 2­nitroethene-1,1-diamine group. Unfortunately, 2-nitroethene-1,1-diamines are more likely to exist as their amidine tautomers, unless a strong electronegative group (e.g.,
) is attached to the C atom (Fig. 7.44).
NO
2
Fig. 7.44: Tautomeric equilibrium.
The compound with the above moiety was more active than one might think. This in­dicates the presence of another variable influencing its biological activity and further studies focused on the orientation of the dipole moment (Fig. 7.45).
Fig. 7.45: Dipole moments of several antagonistic groups.
In Fig. 7.45 the orientation of the dipole moment is defined by the φ angle between the dipole moment and the N–R bond. Compounds with the cyanoguanidino, 2-nitroethene­1,1-diamine, and nitropyrrole groups have a high antagonistic activity and have orienta­tions of the dipole moments of 13°, 33°, and 27°, respectively. The isocitosine and imida-
7.8 Cimetidine development 171
https://t.me/med1917
zolinone groups give rise to a lower activity and have orientations of 2° and −6°, respec­tively. The strength of the dipole moment (μ) does not seem to be crucial.
Adipole–dipole interaction takes place when the drug approaches the binding site. The dipoles line up, orientating the drug, and a good interaction with the binding site occurs if the binding groups are positioned correctly in relatio n to the binding regions. This produces a good activity (Fig. 7.46).
Fig. 7.46: Orientation effects on the receptor active site.
This directs the drug in a specific way before the hydrogen bond takes place and de­termines the strength of the hydrogen bond to be established. If the dipole moment is correctly oriented as in the 2-nitroethene-1,1-diamine analog, the group will be cor­rectly positioned for a strong hydrogen bond and will lead to high activity (Fig. 7.46).
Fig. 7.47: Ideal and observed orientations of the dipole.
QSAR studies were performed to determine the φ optimal angle for the activity. This gave an optimal angle of 30° (Fig. 7.47). A correlation was obtained between the orien­tation of the distribution coefficient and the activity [eq. (7.2)]:
log ð1=CÞ = 9.12 cos φ + 0.6 log π − 2.71 (7:2)
172 7 Histamine and antihistamines
https://t.me/med1917
The term cos φ shows that activity decreases if the orientation of φ separates from the ideal value of 30°. With this ideal angle, φ is 0° and cos 0° = 1, whereby the biological activity is maximal. The 2-nitroethene-1,1-diamine group did not give rise to a more powerful cimetidine analog, but we will see it again in ranitidine.
7.9 Variation of the imidazole ring and the cyanoguanidine moiety of cimetidine: ranitidine
Glaxo showed that the imidazole could be replaced by a furan with a substituent con­taining a nitrogen atom and thus molecule 7.1 was obtained (Fig. 7.48). Nevertheless, its variable melting point and low crystallinity made its pharmaceutical development difficult and the subsequent change of the cyanoguanidino group of 7.1 by the 2­nitroethene-1,1-diamine group gave rise to ranitidine.
Fig. 7.48: Variation of the imidazole ring and the cyanoguanidine moiety of cimetidine to give ranitidine
®
(Zantac
Ranitidine has fewer side effects than cimetidine, lasts longer, and is 4–5 times more active. The SAR results are as follows: – The 2-nitroethene-1,1-diamine group is optimal for activity, but can be replaced
by other π-planar systems capable of forming hydrogen bonds.
– The activity would decrease if a sulfur atom was placed next to the ring. – Replacing the furan with more hydrophobic rings, such as phenyl or thiophene,
reduces activity.
– Di-substitution at 2.5 is the best model for the furan ring. – Substitution of a methyl group at C-3 of the furan ring eliminates the activity,
while the equivalent substitution in the imidazole series increases it.
These results imply that cimetidine and ranitidine do not interact in the same way with the H nitro ethylene di-amino group attached to cimetidine leads to a decrease in activity.
).
receptor. This assertion is supported by the finding that the corresponding
2
7.11 Comparison between H1 and H2 antagonists 173
https://t.me/med1917
7.10 Summary of cimetidine design
The evolution in the development of cimetidine is summarized in Fig. 7.49. Note the change in the tautomeric forms from burimamide to methiamide. The trade name of Tagamet corresponds to the accumulation of uppercase letters of the phrase “anTAG- onist And ciMETidine”.
Fig. 7.49: Evolution in the development of cimetidine.
7.11 Comparison between H1 and H2 antagonists
At the structural level, the differences between the two types of antagonists are quite remarkable, as shown in Fig. 7.50.
H1 antihistamines are compounds with high lipophilicity due to terminal aryl groups. This results in greater penetration into the CNS and central side effects. In contrast, H2 antagonists are polar and hydrophilic molecules, largely due to the high dipole moment of the substituents at the terminal side chain. These substituents pres-
174 7 Histamine and antihistamines
https://t.me/med1917
Fig. 7.50: Structural differences between H1 and H2 antagonists.
ent delocalized and low ionized systems at physiological pH, which explains their lim­ited penetration into the CNS as well as the practical absence of effects at this level.
The work done by Black, Ganellin, and coworkers was a true example of careful rational development, with thoughtful consideration of the chemical properties used to identify the optimal compound. The development of cimetidine represents a break­through in pharmaceutical chemistry in using the physiological approach, which is focused on the selection of a therapeutic target.
7.12 Fundamentals
H1 antihistamines: They are used as antiallergy agents
Phenbenzamine, dimenhydrinate, chlorpheniramine, promethazine, loratadine, and desloratadine
H2 antihistamines → they are used as antiulcer drugs
Evolution in the development of cimetidine N methiamide → cimetidine Preferred tautomeric forms of histamine and burimamide Introduction of the cyanoguanidine group in cimetidine Bredereck reaction Cimetidine synthesis
α
-guanylhistamine burimamide →
8 Enzymatic inhibitors I
https://t.me/med1917
8.1 Goals
– Foster knowledge of the drugs that act at these levels – Foster knowledge of the fundamental role of enzymatic inhibition in the design
of new drugs
– Make the reader aware of the existence of various peptides that play important
roles in life
– Introduce the student to modern antihypertensive drugs
8.2 Introduction
In general, enzymes are simpler pharmacological targets to study than receptors since they are easier to purify and their active sites and their catalysis mechanisms are relatively accessible. It is useful to distinguish between two possible situations when it comes to using an enzyme as a target for drug action: – First, they may be pharmacodynamic enzyme inhibitors, which act when the
causes or symptoms of a disease are due to an alteration of an enzymatic reaction usually occurring in the healthy organism
– Second, there are enzymatic chemotherapeutic inhibitors, which act when a dis-
ease is caused by external agents, generally by bacteria, viruses, fungi, or para­sites. These drugs can inhibit important enzymes for survival that are not found in the host or, if present, can inhibit their function selectively. Chemotherapeutics are also called antitumor agents that act by in hibiting enzymes for which there are only quantitative differences between normal and tumor cells, whereby selec­tive inhibition is practically impossible, at least in vitro
8.3 Carbonic anhydrase (CA) inhibitors
Carbonic anhydrase (CA) is an enzyme that catalyzes the formation of carbonic acid from carbon dioxide and water (Fig. 8.1).
Fig. 8.1: Formation of carbonic acid.
https://doi.org/10.1515/9783111316888-008
176 8 Enzymatic inhibitors I
https://t.me/med1917
CA is located in the walls of the proximal kidney tubule cells and its net effect is the reabsorption of sodium bicarbonate together with the osmotic equivalent of water (Fig. 8.2).
Fig. 8.2: Mechanism of sodium bicarbonate reabsorption by CA.
It has been observed that diuretic effects of certain sulfonamides are associated with their ability to competitively inhibit CA enzymes. This inhibitory action is most com­monlyundertakenbyintheprimarysulfonamides, given their structural analogy with carbonic acid, the natural substrate of the enzyme (Fig. 8.3). A similar interaction with the active center of the enzyme for both types of compounds can be postulated. On the other hand, it is essential that the primary sulfonamide be relatively acidic. This is achieved by introducing electron-withdrawing aromatic systems, such as 1,3,4­thiadiazole, present in various diuretic sulfonamides such as acetazolamide, the first drug of this group (Fig. 8.4).
Fig. 8.3: Interaction of a primary sulfonamide and carbonic acid with the active center of CA.
8.3 Carbonic anhydrase (CA) inhibitors 177
https://t.me/med1917
Fig. 8.4: Acetazolamide.
CA is also found in other tissues where its inhibition may lead to useful therapeutic effects. Thus, since it participates in the formation of aqueous humor, CA inhibitors (CAIs) will lead to a decrease in the reuptake of sodium bicarbonate and water from the tear to the aqueous humor, which is useful in the treatment of glaucoma (Fig. 8.5).
Fig. 8.5: Decreased aqueous humor volume: utility in the treatment of glaucoma.
With the prolonged use of diuretic CAs, urine becomes more alkaline and blood be­comes more acidic. When acidosis occurs, CAs lose efficacy as diuretics and remain ineffective until the body’s acid-base balance is restored. For this reason, this class of compounds has a limited utility as diuretics. Today, they are most commonly used in the treatment of glaucoma, in which they inhibit CA in the eye, reduce the rate of aqueous humor formation, and consequently reduce intraocular pressure.
Research in the field of diuretic sulfonamides has been very successful in recent years. Through molecular modifications of CA inhibitors, diuretic sulfonamides that are structurally related, but are governed by different mechanisms to those outlined